SCHEMBL18974299

SCHEMBL18974299

Cc1cccc(CN2C(=O)C(=O)c3ccccc32)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.69
CES1 P23141 6/20 0.69
ALDH3A1 P30838 5/20 0.69
ALDH2 P05091 4/20 0.69
CHRM1 P11229 2/20 0.69
HPGD P15428 1/20 0.64
HTT P42858 1/20 0.64
BCHE P06276 4/20 0.62
ACHE P22303 3/20 0.62
APAF1 O14727 1/20 0.62
TP53 P04637 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2D6 P10635 1/20 0.62
MAPT P10636 1/20 0.62
ALOX15 P16050 1/20 0.62
TSHR P16473 1/20 0.62
ALOX12 P18054 1/20 0.62
HSD17B10 Q99714 1/20 0.62
TDP1 Q9NUW8 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18974147 0.88 CES1 (0.69) ALDH1A1CES1ALDH3A1ALDH2CHRM1
SCHEMBL16111939 0.86 ALDH1A1 (0.71) ALDH1A1CES1ALDH3A1ALDH2CHRM1
SCHEMBL18954739 0.85 ALDH1A1 (0.69) ALDH1A1CES1ALDH3A1ALDH2CHRM1
SCHEMBL10975507 0.83 CES1 (0.77) ALDH1A1CES1ALDH3A1ALDH2CHRM1
SCHEMBL30774290 0.83 CES1 (0.77) ALDH1A1CES1ALDH3A1ALDH2CHRM1
SCHEMBL10922984 0.83 KMT2A (0.60) HPGDHTTMAPTALOX15TSHR
SCHEMBL29819860 0.83 KMT2A (0.60) HPGDHTTMAPTALOX15TSHR
Hydrochloric Acid SCHEMBL9094800 0.83 DRD2 (0.66) ALDH1A1CES1ALDH3A1ALDH2CHRM1
SCHEMBL29506660 0.82 ALDH1A1 (1.00) ALDH1A1CES1ALDH3A1ALDH2CHRM1
SCHEMBL2087729 0.82 ALDH1A1 (1.00) ALDH1A1CES1ALDH3A1ALDH2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed